EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimized Dynamic Network Biomarker Deciphers a High‐Resolution Heterogeneity Within Thyroid Cancer Molecular Subtypes

Haonan Zhang, Ge Zhang, Pengyuan Xu, Fengyi Yu, Liwen Li, Runzhi Huang, Pengpeng Zhang, Kaisaierjiang Kadier, Yuanyuan Wang, Qiqi Gu, Yalei Ding, Tianshu Gu und 9 weitere

Med Research · 2025

DOI: 10.1002/mdr2.70004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Med Research, 2025. Verfasst von Haonan Zhang und 20 weiteren Autor:innen. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The progression of differentiated thyroid carcinoma (DTC) poses significant clinical challenges, especially in determining the optimal time for intervention. To capture early signals of disease progression, we employed an optimized dynamic network biomarker (DNB) method—a systems biology approach that detects abrupt molecular changes indicating a critical transition signal. This analysis revealed that Stage II marks a critical transition in the disease trajectory. We further developed a scoring system called TCPSLevel (Thyroid Carcinoma Progression Signature Level), which quantifies individual progression risk based on gene expression profiles. TCPSLevel showed strong associations with clinical features and prognosis across multiple datasets. Our ensemble consensus clustering approach uncovered three robust DTC molecular subtypes, which demonstrated distinct clinical outcomes, immune microenvironments, regulatory landscapes, and therapeutic agents. A clinically applicable classifier (miniPC) was constructed using machine learning to facilitate subtype prediction. We also identified ASPH as a key regulator driving progression and validated its expression and function experimentally. Together, these findings offer new insights and practical tools for early risk assessment and personalized management of thyroid cancer.

Zitieren

APA

Zhang, H., Zhang, G., Xu, P., Yu, F., Li, L., Huang, R., Zhang, P., Kadier, K., Wang, Y., Gu, Q., Ding, Y., Gu, T., Chi, H., Zhang, S., Wu, R., Xu, Y., Zhu, S., Zheng, H., Zhao, T., …, & Qiu, X. (2025). Optimized Dynamic Network Biomarker Deciphers a High‐Resolution Heterogeneity Within Thyroid Cancer Molecular Subtypes. Med Research. https://doi.org/10.1002/mdr2.70004

Vancouver

Zhang H, Zhang G, Xu P, Yu F, Li L, Huang R, et al. Optimized Dynamic Network Biomarker Deciphers a High‐Resolution Heterogeneity Within Thyroid Cancer Molecular Subtypes. Med Research. 2025. doi:10.1002/mdr2.70004

BibTeX
@article{Zhang2025,
  author = {Zhang, Haonan and Zhang, Ge and Xu, Pengyuan and Yu, Fengyi and Li, Liwen and Huang, Runzhi and Zhang, Pengpeng and Kadier, Kaisaierjiang and Wang, Yuanyuan and Gu, Qiqi and Ding, Yalei and Gu, Tianshu and Chi, Hao and Zhang, Shiqian and Wu, Ruhao and Xu, Yudi and Zhu, Shanshan and Zheng, Honglin and Zhao, Taiqi and He, Qi and Qiu, Xinguang},
  title = {Optimized Dynamic Network Biomarker Deciphers a High‐Resolution Heterogeneity Within Thyroid Cancer Molecular Subtypes},
  journal = {Med Research},
  year = {2025},
  doi = {10.1002/mdr2.70004}
}
Kostenlos starten →